{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:07:11Z","timestamp":1789726031948,"version":"4.0.1"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016263","name":"Penn Center for AIDS Research Center Developmental Pilot Award","doi-asserted-by":"publisher","award":["P30AI045008"],"award-info":[{"award-number":["P30AI045008"]}],"id":[{"id":"10.13039\/100016263","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Transgender individuals face disproportionate HIV burden yet experience significant barriers to accessing biomedical HIV prevention. We assessed awareness, experience, and willingness among trans adults to use pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) when integrated with telehealth-delivered gender-affirming hormone care (GAC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a cross-sectional survey of clients receiving GAHC via a national subscription-based telehealth platform between October 2023 and January 2024. Using stratified sampling to ensure inclusion of transgender men (TGM) and those residing in rural areas, we assessed PrEP\/PEP awareness, prior use, barriers, and willingness to use these services if recommended by their GAC provider. Multivariable logistic regression identified factors associated with stated willingness (yes\/no).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 387 respondents (from 2506 survey invitations, 15.4% response rate), 54.8% identified as transgender women (TGW), 45% were between the ages of 18 and 25, and 74% identified as white, and 13% resided in rural areas. Pre-exposure prophylaxis awareness was moderate among TGW (56%) and TGM (69%), while PEP awareness was 24% among TGW and 31% among TGM. Only 2% of TGW were using PrEP (0% of TGM), and 0% had used PEP. Despite limited prior utilization, 67% expressed willingness to use PrEP and 66% willingness to use PEP if recommended by their GAC provider. Public insurance (vs private) and self-reported HIV worry (vs not worried) were associated with willingness to use both PrEP (public insurance: aOR 3.64, P = .022; HIV worry: aOR 2.57, P = .002) and PEP (public insurance: aOR 3.48, P = .032; HIV worry: aOR 2.41, P = .004). Prior awareness of PEP was also associated with willingness to use it (aOR 2.06, 95% CI 1.08\u20133.94, P = .030).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among clients of a subscription-based telehealth platform, stated acceptability of integrated PrEP\/PEP services was high regardless of gender identity or geography. Limited awareness, cost concerns, and the large gap between awareness and utilization require further attention to realize the potential benefits of biomedical HIV prevention integration into telehealth GAC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofag548","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:34:37Z","timestamp":1787657677000},"source":"Crossref","is-referenced-by-count":0,"title":["Perspectives on PrEP\/PEP Integration in Telehealth Gender-Affirming Care: A Survey of Clients From a National Telehealth Platform"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3592-1905","authenticated-orcid":false,"given":"Nancy","family":"Aitcheson","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania ,","place":["USA"]},{"name":"Penn Leonard Davis Institute of Health Economics , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8225-4554","authenticated-orcid":false,"given":"Yun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital of Philadelphia , Philadelphia, Pennsylvania ,","place":["USA"]},{"name":"Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine of the University of Pennsylvania , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital of Philadelphia , Philadelphia, Pennsylvania ,","place":["USA"]},{"name":"Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine of the University of Pennsylvania , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline S","family":"O'Brien","sequence":"additional","affiliation":[{"name":"Mixed Methods Research Lab, Department of Family Medicine and Community Health, University of Pennsylvania Perelman School of Medicine , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moira","family":"Kyweluk","sequence":"additional","affiliation":[{"name":"Third Space Research , Philadelphia, Pennsylvania ,","place":["USA"]},{"name":"Plume Health, Inc. , Denver, Colorado ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8466-1628","authenticated-orcid":false,"given":"Nadia","family":"Dowshen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital of Philadelphia , Philadelphia, Pennsylvania ,","place":["USA"]},{"name":"Clinical Futures, Children\u2019s Hospital of Philadelphia , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6287-0373","authenticated-orcid":false,"given":"Florence","family":"Momplaisir","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania ,","place":["USA"]},{"name":"Penn Leonard Davis Institute of Health Economics , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"2026091805313015200_ofag548-B1","author":"Centers for Disease Control and Prevention"},{"key":"2026091805313015200_ofag548-B2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2105\/AJPH.2018.304727","article-title":"Estimating the prevalence of HIV and sexual behaviors among the US transgender population: a systematic review and meta-analysis, 2006-2017","volume":"109","author":"Becasen","year":"2019","journal-title":"Am J Public Health"},{"key":"2026091805313015200_ofag548-B3","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1097\/QAI.0000000000001087","article-title":"Global epidemiology of HIV infection and related syndemics affecting transgender people","volume":"72","author":"Poteat","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026091805313015200_ofag548-B4","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"2026091805313015200_ofag548-B5","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25539","article-title":"Disparities in the PrEP continuum for trans women compared to MSM in San Francisco, California: results from population-based cross-sectional behavioural surveillance studies","volume":"23","author":"Wilson","year":"2020","journal-title":"J Int AIDS Soc"},{"key":"2026091805313015200_ofag548-B6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/QAI.0000000000003512","article-title":"Brief report: availability of and interest in gender-affirming care, PrEP, and HIV prevention services in a global sample of transmasculine persons","volume":"97","author":"Paine","year":"2024","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026091805313015200_ofag548-B7","author":"New York City Department of Health and Mental Hygiene. Laboratory of Infectious Disease Prevention and New York Blood Center","year":"2017"},{"key":"2026091805313015200_ofag548-B8","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1093\/cid\/civ069","article-title":"Efficacy of HIV postexposure prophylaxis: systematic review and meta-analysis of nonhuman primate studies","volume":"60","author":"Irvine","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2026091805313015200_ofag548-B9","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/26895269.2024.2351456","article-title":"Exploring the universe of HIV post-exposure prophylaxis in trans women: a qualitative analysis of access, use and adherence","volume":"26","author":"Dos Santos","year":"2024","journal-title":"Int J Transgend Health"},{"key":"2026091805313015200_ofag548-B10","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1080\/17441692.2016.1154085","article-title":"\u2018I am not a man': trans-specific barriers and facilitators to PrEP acceptability among transgender women","volume":"11","author":"Sevelius","year":"2016","journal-title":"Glob Public Health"},{"key":"2026091805313015200_ofag548-B11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jadohealth.2016.12.004","article-title":"Young transgender women's attitudes toward HIV pre-exposure prophylaxis","volume":"60","author":"Wood","year":"2017","journal-title":"J Adolesc Health"},{"key":"2026091805313015200_ofag548-B12","volume-title":"The report of the 2015U.S. Transgender survey","author":"James","year":"2016"},{"key":"2026091805313015200_ofag548-B13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.socscimed.2013.02.019","article-title":"Managing uncertainty: a grounded theory of stigma in transgender health care encounters","volume":"84","author":"Poteat","year":"2013","journal-title":"Soc Sci Med"},{"key":"2026091805313015200_ofag548-B14","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1097\/QAI.0000000000001088","article-title":"Integrated and gender-affirming transgender clinical care and research","volume":"72","author":"Reisner","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026091805313015200_ofag548-B15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.amepre.2017.11.009","article-title":"Gender identity disparities in cancer screening behaviors","volume":"54","author":"Tabaac","year":"2018","journal-title":"Am J Prev Med"},{"key":"2026091805313015200_ofag548-B16","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1007\/s11606-015-3462-8","article-title":"Cervical cancer screening for patients on the female-to-male spectrum: a narrative review and guide for clinicians","volume":"30","author":"Potter","year":"2015","journal-title":"J Gen Intern Med"},{"key":"2026091805313015200_ofag548-B17","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1016\/S2352-3018(25)00004-9","article-title":"HIV seropositivity and viral non-suppression in transgender, non-binary, and gender-diverse people in primary care receiving gender-affirming hormone therapy in the USA between 2013 and 2019 (LEGACY): an observational, longitudinal, cohort study","volume":"12","author":"Reisner","year":"2025","journal-title":"Lancet HIV"},{"key":"2026091805313015200_ofag548-B18","doi-asserted-by":"crossref","first-page":"29010","DOI":"10.1038\/s41598-025-97797-4","article-title":"Utilization of telemedicine in healthcare delivery to lesbian, gay, bisexual, transgender, queer, intersex, asexual, other sexual and gender minority (LGBTQIA+) populations: a scoping review","volume":"15","author":"Goyal","year":"2025","journal-title":"Sci Rep"},{"key":"2026091805313015200_ofag548-B19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.46792","article-title":"Telemedicine preexposure prophylaxis prescribing from a large online US company","volume":"8","author":"Siegler","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026091805313015200_ofag548-B20","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s11904-020-00528-9","article-title":"A review of HIV pre-exposure prophylaxis streamlining strategies","volume":"17","author":"Siegler","year":"2020","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2026091805313015200_ofag548-B21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/QAI.0000000000001251","article-title":"Uptake of HIV Pre-exposure prophylaxis (PrEP) in a national cohort of gay and bisexual men in the United States","volume":"74","author":"Parsons","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026091805313015200_ofag548-B22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128971","article-title":"Knowledge, indications and willingness to take pre-exposure prophylaxis among transwomen in San Francisco, 2013","volume":"10","author":"Wilson","year":"2015","journal-title":"PLoS One"},{"key":"2026091805313015200_ofag548-B23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1089\/apc.2012.0419","article-title":"From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City","volume":"27","author":"Golub","year":"2013","journal-title":"AIDS Patient Care STDS"},{"key":"2026091805313015200_ofag548-B24","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25391","article-title":"High risk and low uptake of pre-exposure prophylaxis to prevent HIV acquisition in a national online sample of transgender men who have sex with men in the United States","volume":"22","author":"Reisner","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"2026091805313015200_ofag548-B25","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1007\/s10461-018-2175-5","article-title":"Post-exposure prophylaxis awareness, knowledge, access and use among three populations in New York City, 2016\u201317","volume":"22","author":"Koblin","year":"2018","journal-title":"AIDS Behav"},{"key":"2026091805313015200_ofag548-B26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/QAI.0000000000003492","article-title":"PrEP use in a US national sample of trans men and other transmasculine people who have sex with men: a longitudinal analysis","volume":"97","author":"Carneiro","year":"2024","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026091805313015200_ofag548-B27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.15585\/mmwr.su7301a2","article-title":"Characteristics associated with Pre-exposure prophylaxis discussion and use among transgender women without HIV infection national HIV behavioral surveillance among transgender women, seven urban areas, United States, 2019\u20132020","volume":"73","author":"Morris","year":"2024","journal-title":"MMWR Suppl"},{"key":"2026091805313015200_ofag548-B28","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1007\/s10461-023-03983-8","article-title":"Understanding barriers and facilitators of Pre-exposure prophylaxis (PrEP) among transgender and gender diverse adults in an integrated health care system","volume":"27","author":"Bruxvoort","year":"2023","journal-title":"AIDS Behav"},{"key":"2026091805313015200_ofag548-B29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1089\/apc.2021.0236","article-title":"Barriers and facilitators to HIV Pre-exposure prophylaxis uptake, adherence, and persistence among transgender populations in the United States: a systematic review","volume":"36","author":"Dang","year":"2022","journal-title":"AIDS Patient Care STDS"},{"key":"2026091805313015200_ofag548-B30","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1007\/s10461-016-1480-0","article-title":"Exploring patterns of awareness and use of HIV pre-exposure prophylaxis among young men who have sex with men","volume":"21","author":"Strauss","year":"2017","journal-title":"AIDS Behav"},{"key":"2026091805313015200_ofag548-B31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12160-013-9565-8","article-title":"Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus","volume":"47","author":"Sevelius","year":"2014","journal-title":"Ann Behav Med"},{"key":"2026091805313015200_ofag548-B32","doi-asserted-by":"crossref","DOI":"10.7448\/IAS.19.7.21105","article-title":"The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices","volume":"19","author":"Sevelius","year":"2016","journal-title":"J Int AIDS Soc"},{"key":"2026091805313015200_ofag548-B33","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.26211","article-title":"HIV pre-exposure prophylaxis programme preferences among sexually active HIV-negative transgender and gender diverse adults in the United States: a conjoint analysis","volume":"27","author":"Watson","year":"2024","journal-title":"J Int AIDS Soc"},{"key":"2026091805313015200_ofag548-B34","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1089\/apc.2019.0049","article-title":"Increasing access to Pre-exposure prophylaxis among transgender women and transfeminine nonbinary individuals","volume":"33","author":"Klein","year":"2019","journal-title":"AIDS Patient Care STDS"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofag548\/70819347\/ofag548.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/9\/ofag548\/70819347\/ofag548.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/9\/ofag548\/70819347\/ofag548.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:31:45Z","timestamp":1789723905000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag548\/8771816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag548","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,8,27]]},"article-number":"ofag548"}}